Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael P Sanderson

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 27, 2019
Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug DiscoveryJulia C Meier-Hubberten, Michael P Sanderson
Growth Factors (Chur, Switzerland)|June 28, 2006
Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factorsMichael P Sanderson, Peter J Dempsey, Andrew J Dunbar
Immunology Letters|October 28, 2006
Exosomes: from biogenesis and secretion to biological functionSascha Keller, Michael P Sanderson, Alexander Stoeck, et al.
Inflammation & Allergy Drug Targets|June 18, 2009
Syk: a novel target for treatment of inflammation in lung diseaseMichael P Sanderson, Christine W Lau, Andreas Schnapp, et al.
Cellular Immunology|January 8, 2010
Comparison of the anti-allergic activity of Syk inhibitors with optimized Syk siRNAs in FcepsilonRI-activated RBL-2H3 basophilic cellsMichael P Sanderson, Stephen J Gelling, Jörg F Rippmann, et al.
Molecular Immunology|September 11, 2010
Syk and Lyn mediate distinct Syk phosphorylation events in FcɛRI-signal transduction: implications for regulation of IgE-mediated degranulationMichael P Sanderson, Eva Wex, Takeshi Kono, et al.
Gynecologic Oncology|October 13, 2006
L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cellsAlexander Stoeck, Daniela Gast, Michael P Sanderson, et al.
Journal of Cellular Biochemistry|October 3, 2007
Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretionMichael P Sanderson, Sascha Keller, Angel Alonso, et al.
Journal of Cellular Biochemistry|May 6, 2006
Hydrogen peroxide and endothelin-1 are novel activators of betacellulin ectodomain sheddingMichael P Sanderson, Catherine A Abbott, Hiroko Tada, et al.
Cancer Chemotherapy and Pharmacology|March 1, 2017
An allometric pharmacokinetic/pharmacodynamics model for BI 893923, a novel IGF-1 receptor inhibitorMelanie I Titze, Otmar Schaaf, Marco H Hofmann, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Methods in Molecular Biology (Clifton, N.J.)|March 27, 2019
Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug DiscoveryJulia C Meier-Hubberten, Michael P Sanderson
Growth Factors (Chur, Switzerland)|June 28, 2006
Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factorsMichael P Sanderson, Peter J Dempsey, Andrew J Dunbar
Immunology Letters|October 28, 2006
Exosomes: from biogenesis and secretion to biological functionSascha Keller, Michael P Sanderson, Alexander Stoeck, et al.
Inflammation & Allergy Drug Targets|June 18, 2009
Syk: a novel target for treatment of inflammation in lung diseaseMichael P Sanderson, Christine W Lau, Andreas Schnapp, et al.
Cellular Immunology|January 8, 2010
Comparison of the anti-allergic activity of Syk inhibitors with optimized Syk siRNAs in FcepsilonRI-activated RBL-2H3 basophilic cellsMichael P Sanderson, Stephen J Gelling, Jörg F Rippmann, et al.
Molecular Immunology|September 11, 2010
Syk and Lyn mediate distinct Syk phosphorylation events in FcɛRI-signal transduction: implications for regulation of IgE-mediated degranulationMichael P Sanderson, Eva Wex, Takeshi Kono, et al.
Gynecologic Oncology|October 13, 2006
L1-CAM in a membrane-bound or soluble form augments protection from apoptosis in ovarian carcinoma cellsAlexander Stoeck, Daniela Gast, Michael P Sanderson, et al.
Journal of Cellular Biochemistry|October 3, 2007
Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease-dependent ectodomain shedding and exosome secretionMichael P Sanderson, Sascha Keller, Angel Alonso, et al.
Journal of Cellular Biochemistry|May 6, 2006
Hydrogen peroxide and endothelin-1 are novel activators of betacellulin ectodomain sheddingMichael P Sanderson, Catherine A Abbott, Hiroko Tada, et al.
Cancer Chemotherapy and Pharmacology|March 1, 2017
An allometric pharmacokinetic/pharmacodynamics model for BI 893923, a novel IGF-1 receptor inhibitorMelanie I Titze, Otmar Schaaf, Marco H Hofmann, et al.
Pageof 3